CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $489,000 | -26.2% | 19,402 | -18.5% | 0.01% | -15.4% |
Q1 2015 | $663,000 | +52.8% | 23,802 | 0.0% | 0.01% | +62.5% |
Q4 2014 | $434,000 | -49.8% | 23,802 | -64.3% | 0.01% | -46.7% |
Q3 2014 | $865,000 | -13.8% | 66,732 | +8.6% | 0.02% | -6.2% |
Q2 2014 | $1,003,000 | +277.1% | 61,442 | +307.7% | 0.02% | +300.0% |
Q1 2014 | $266,000 | -57.0% | 15,072 | -40.9% | 0.00% | -63.6% |
Q4 2013 | $618,000 | – | 25,508 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
LMR Partners LLP | 408,846 | $206,000 | 0.01% |